Company / Free Cash Flow
Annexon, Inc. Free Cash Flow History
FY2019-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Free Cash Flow
-$118.0M
FY2024
5-year range
-$122.8M / -$53.6M
FY2020-FY2024
Trend
+2.7%
vs FY2023
Sector context
#114 of 192
Health Care
What the data says
At -$118M, Annexon, Inc.'s free cash flow ranks #114 of 192 in the Health Care sector. Improved from -$123M to -$118M over the past 2 years.
Based on SEC 10-K filings.
-$118M in FY2024.
Improved from -$123M to -$118M over the past 2 years.
Health Care sector context is included.
Free Cash Flow over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#114 of 192 in Health CareTop 59% of 192This company -$118.0M Sector average $474.2M
▼
-124.9% below sector average
Key checks
Key Insights
- In FY2024, free cash flow increased 2.7% year-over-year.
- Ranks #114 out of 192 companies in the Health Care sector.
- Peak free cash flow was recorded in FY2019.
- Lowest free cash flow in the period was in FY2022.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Free Cash FlowValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | -$118.0M | +2.7% |
| FY2023 | -$121.3M | +1.2% |
| FY2022 | -$122.8M | -14.0% |
| FY2021 | -$107.8M | -101.2% |
| FY2020 | -$53.6M | -87.1% |
| FY2019 | -$28.6M | - |
As of FY2024 · SEC 10-K · Updated Feb 28, 2026